Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.23 -0.04 (-0.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Return on Assets [ROA] (2021 - 2026)

Updated

Olema Pharmaceuticals (OLMA) recorded Return on Assets [ROA] of -40.15% in Q2 2026, down 4.19 percentage points from -35.96% a year earlier and down 5.31 percentage points from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Olema Pharmaceuticals reported Return on Assets [ROA] of -33.01%, up 2.59 percentage points from FY2024.

  • Annual Return on Assets [ROA] has increased for three straight years, though with a four-year change of -10.76 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -35.60% in FY2024 (+3.63 pp), -39.24% in FY2023 (+1.72 pp), -40.95% in FY2022 (-18.71 pp) and -22.25% in FY2021.
  • Quarterly Return on Assets [ROA] has ranged from -53.48% in Q1 2023 to -18.84% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] rose in four of the last eight quarters, with an average year-over-year change of +0.17 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 16.74 percentage points in Q1 2024, against a drop of 26.02 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -34.83% (Q1 2026), -36.68% (Q4 2025) and -40.81% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Olema Pharmaceuticals 719.73 Mn 719.73 Mn - -40.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.15%
Mar 31, 2026 -34.83%
Dec 31, 2025 -36.68%
Sep 30, 2025 -40.81%
Jun 30, 2025 -35.96%
Mar 31, 2025 -29.96%
Dec 31, 2024 -38.05%
Sep 30, 2024 -50.74%
Jun 30, 2024 -42.33%
Mar 31, 2024 -36.74%
Dec 31, 2023 -33.92%
Sep 30, 2023 -40.82%
Jun 30, 2023 -52.06%
Mar 31, 2023 -53.48%
Dec 31, 2022 -46.81%
Sep 30, 2022 -41.51%
Jun 30, 2022 -36.07%
Mar 31, 2022 -27.47%
Dec 31, 2021 -23.46%
Sep 30, 2021 -18.84%
API Access

Olema Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OLMA&period=max&api_key=YOUR_API_KEY